Literature DB >> 15492282

Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.

Hsing-Wen Wang1, Mary E Putt, Michael J Emanuele, Daniel B Shin, Eli Glatstein, Arjun G Yodh, Theresa M Busch.   

Abstract

Photodynamic therapy (PDT) requires oxygen to cause tumor damage, yet therapy itself can deplete or enhance tumor oxygenation. In the present work we measured the PDT-induced change in tumor oxygenation and explored its utility for predicting long-term response to treatment. The tissue hemoglobin oxygen saturation (SO(2)) of murine tumors was noninvasively measured by broadband diffuse reflectance spectroscopy. In initial validation studies, the oxyhemoglobin dissociation curve for mouse blood was accurately recreated based on measurements during deoxygenation of a tissue phantom of mouse erythrocytes. In vivo studies exhibited excellent correlation between carbogen-induced changes in SO(2) and pO(2) of radiation-induced fibrosarcoma tumors measured by reflectance spectroscopy and the Eppendorf pO(2) histograph, respectively. In PDT studies radiation-induced fibrosarcoma tumor SO(2) was measured immediately before and after Photofrin-PDT (135 J/cm(2), 38 mW/cm(2)). Animals were subsequently followed for tumor growth to a volume of 400 mm(3) (time-to-400 mm(3)) or the presence of tumor cure (no tumor growth at 90 days after treatment). In animals that recurred, the PDT-induced change in tumor SO(2), i.e., relative-SO(2) (SO(2) after PDT/SO(2) before PDT) was positively correlated with treatment durability (time-to-400 mm(3)). The predictive value of relative-SO(2) was confirmed in a second group of animals with enhanced pre-PDT oxygenation due to carbogen breathing. Furthermore, when all of the animals were considered (those that recurred and those that were cured) a highly significant association was found between increasing relative-SO(2) and increasing probability of survival, i.e., absence of recurrence. As independent variables, the SO(2) after PDT, the pre-PDT tumor volume, and light penetration depth all failed to predict response. As an independent variable, the SO(2) before PDT demonstrated a weak negative association with treatment durability; this association was driven by a correlation between decreasing pre-PDT SO(2) and increasing relative-SO(2). These data suggest that monitoring of PDT-induced changes in tumor oxygenation may be a valuable prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492282     DOI: 10.1158/0008-5472.CAN-03-3632

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.

Authors:  Theresa M Busch; Hsing-Wen Wang; E Paul Wileyto; Guoqiang Yu; Ralph M Bunte
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

3.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Authors:  Daniel J Rohrbach; Nestor Rigual; Hassan Arshad; Erin C Tracy; Michelle T Cooper; Gal Shafirstein; Gregory Wilding; Mihai Merzianu; Heinz Baumann; Barbara W Henderson; Ulas Sunar
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

Review 4.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

Review 5.  The role of photodynamic therapy (PDT) physics.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

6.  Determination of the low concentration correction in the macroscopic singlet oxygen model for PDT.

Authors:  Michele M Kim; Rozhin Penjweini; Jarod C Finlay; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-17

7.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.

Authors:  Theresa M Busch; Xiaoman Xing; Guoqiang Yu; Arjun Yodh; E Paul Wileyto; Hsing-Wen Wang; Turgut Durduran; Timothy C Zhu; Ken Kang-Hsin Wang
Journal:  Photochem Photobiol Sci       Date:  2009-10-15       Impact factor: 3.982

8.  A light emitting diode (LED) based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging.

Authors:  R B Saager; D J Cuccia; S Saggese; K M Kelly; A J Durkin
Journal:  Lasers Surg Med       Date:  2013-04       Impact factor: 4.025

9.  Hemodynamic and metabolic diffuse optical monitoring in a mouse model of hindlimb ischemia.

Authors:  Rickson C Mesquita; Nicolas Skuli; Meeri N Kim; Jiaming Liang; Steve Schenkel; Amar J Majmundar; M Celeste Simon; Arjun G Yodh
Journal:  Biomed Opt Express       Date:  2010-10-15       Impact factor: 3.732

10.  Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.

Authors:  George J Cerniglia; Nabendu Pore; Jeff H Tsai; Susan Schultz; Rosemarie Mick; Regine Choe; Xiaoman Xing; Turgut Durduran; Arjun G Yodh; Sydney M Evans; Cameron J Koch; Stephen M Hahn; Harry Quon; Chandra M Sehgal; William M F Lee; Amit Maity
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.